OMEROS CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.35 USD | +1.82% |
|
-2.90% | +2.45% |
| May. 16 | Health Care Flat as Momentum Wanes -- Health Care Roundup | DJ |
| May. 15 | Transcript : Omeros Corporation, Q1 2024 Earnings Call, May 15, 2024 |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 762.8 | 880.7 | 402.1 | 141.8 | 205.6 | 194.1 | - | - |
| Enterprise Value (EV) 1 | 762.8 | 1,110 | 587.5 | 284.6 | 205.6 | 194.1 | 194.1 | 194.1 |
| P/E ratio | -8.24 x | -5.93 x | 2.06 x | 2.97 x | -1.74 x | -1.39 x | -1.69 x | -2.06 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 6.82 x | 11.9 x | 3.6 x | - | - | - | 29.9 x | 8.63 x |
| EV / Revenue | 6.82 x | 11.9 x | 3.6 x | - | - | - | 29.9 x | 8.63 x |
| EV / EBITDA | - | -8,080,963 x | -2,334,928 x | -872,769 x | - | - | - | - |
| EV / FCF | - | - | -3,655,915 x | - | - | - | - | - |
| FCF Yield | - | - | -0% | - | - | - | - | - |
| Price to Book | - | -7.3 x | 17 x | 1.66 x | - | - | - | - |
| Nbr of stocks (in thousands) | 54,137 | 61,652 | 62,542 | 62,730 | 62,865 | 57,944 | - | - |
| Reference price 2 | 14.09 | 14.28 | 6.430 | 2.260 | 3.270 | 3.350 | 3.350 | 3.350 |
| Announcement Date | 3/2/20 | 3/1/21 | 3/1/22 | 3/13/23 | 4/1/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 111.8 | 73.81 | 111.8 | - | - | - | 6.5 | 22.5 |
| EBITDA | - | -109 | -172.2 | -162.4 | - | - | - | - |
| EBIT 1 | -63.38 | -110.6 | -173.6 | -163.4 | -164.5 | -170.8 | -162.4 | -147.2 |
| Operating Margin | -56.69% | -149.84% | -155.33% | - | - | - | -2,497.69% | -654.44% |
| Earnings before Tax (EBT) 1 | -84.49 | -150.1 | -191.5 | -182 | -174.9 | -177.6 | -170.2 | -173.3 |
| Net income 1 | -84.49 | -138.1 | 194.2 | 47.42 | -117.8 | -153.8 | -143.6 | -121.2 |
| Net margin | -75.57% | -187.04% | 173.78% | - | - | - | -2,209.23% | -538.44% |
| EPS 2 | -1.710 | -2.410 | 3.120 | 0.7600 | -1.880 | -2.410 | -1.985 | -1.630 |
| Free Cash Flow | - | - | -110 | - | - | - | - | - |
| FCF margin | - | - | -98.42% | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 3/2/20 | 3/1/21 | 3/1/22 | 3/13/23 | 4/1/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 31.88 | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | -42.56 | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | -42.89 | -35.05 | -37.44 | -50.77 | -40.14 | -35.71 | -40.9 | -48.15 | -39.76 | -39.03 | -47.55 | -42.45 | -42.25 |
| Operating Margin | -134.53% | - | - | - | - | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | -47.31 | -33.01 | -41.7 | -54.79 | -46.05 | -39.68 | -44.29 | -51.66 | -39.29 | -43.85 | -55.6 | -42.5 | -42.3 |
| Net income 1 | 280.6 | -33.01 | -30.85 | -17.46 | 128.7 | -33.7 | -37.29 | -37.75 | -9.068 | -37.18 | -43.3 | -37.75 | -36.65 |
| Net margin | 880.24% | - | - | - | - | - | - | - | - | - | - | - | - |
| EPS 2 | 4.480 | -0.5300 | -0.4900 | -0.2800 | 2.050 | -0.5400 | -0.5900 | -0.6000 | -0.1500 | -0.6300 | -0.6950 | -0.5750 | -0.5400 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 3/1/22 | 5/10/22 | 8/9/22 | 11/9/22 | 3/13/23 | 5/9/23 | 8/9/23 | 11/9/23 | 4/1/24 | 5/15/24 | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | 230 | 185 | 143 | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | -2.106 x | -1.076 x | -0.8791 x | - | - | - | - |
| Free Cash Flow | - | - | -110 | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | 120% | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | -63.8% | - | - | - | - | - |
| Assets 1 | - | - | -304.4 | - | - | - | - | - |
| Book Value Per Share | - | -1.960 | 0.3800 | 1.360 | - | - | - | - |
| Cash Flow per Share | - | -1.750 | -1.760 | -1.380 | - | - | - | - |
| Capex | 0.33 | 0.28 | 0.28 | 0.11 | - | - | - | - |
| Capex / Sales | 0.3% | 0.38% | 0.25% | - | - | - | - | - |
| Announcement Date | 3/2/20 | 3/1/21 | 3/1/22 | 3/13/23 | 4/1/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
3.35
Average target price
-
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.45% | 194M | |
| +12.30% | 118B | |
| +12.15% | 106B | |
| -8.14% | 23.4B | |
| -1.69% | 21.78B | |
| -10.60% | 18.09B | |
| -41.25% | 16.72B | |
| -15.33% | 15.97B | |
| +5.80% | 14.03B | |
| +28.03% | 11.67B |
- Stock Market
- Equities
- OMER Stock
- Financials Omeros Corporation
